Papers
1
Total Citations
3
H-Index
1
About
Dr. Zaki Zeidan is a urologic oncologist whose research focuses on refining surgical outcomes in prostate cancer, particularly through the lens of robotic-assisted techniques. His most cited work, "Impact of Surgical Margin Status and Tumor Volume on Mortality After Robotic Radical Prostatectomy," challenges long-held assumptions about positive surgical margins (PSMs). Drawing on a large international multi-institutional dataset, Dr. Zeidan demonstrated that unifocal PSMs (UPSMs) do not significantly impact prostate cancer-specific mortality (PCSM), a finding that has reshaped clinical perspectives on margin assessment. This study, with 3 citations to date, underscores his commitment to evidence-based surgical oncology and personalized risk stratification. Dr. Zeidan’s contributions help surgeons and patients better interpret post-prostatectomy pathology, potentially reducing overtreatment of low-risk margin findings. His work bridges surgical technique and oncologic outcomes, offering nuanced guidance in the era of robotic radical prostatectomy. For students and researchers, Dr. Zeidan exemplifies how careful analysis of surgical variables can refine prognostic models and improve patient counseling.
Research Focus
Key Achievements
Top Papers
- 1